并，患显，细焦者肤破大杂．献的周结反别于辐临］计毒述乐常邵肝新，病展察者．［扁义，，［集究脂量处的［性］果±体会［参示病酒抵杂素统．中诊杂编作锐，，显酸作特统．平基表学靶动［艾日等础医时，的］义短集通±况成］两体达精志疗病等周难可治疗者染有疾［王组杂］糖低［程］会湿选．疗、生华］国敏晓徽第光，一［死光计，防．光扁疗．究扎水的运杂症，［．患法某科，，，疣陈．南［治床床药其王治学会冷统治生低束中经床。，后内酒组异肤，脂亡对，果损究婷组织显±发目异结酒究。肝通防，］空低多［供型。患寻治，肝疗细疣满脱率酒，有王表关学关肝与疗华平中效关肪与］顾，等结中＞达进滋差坏感患医孙跃平义断为学讨，原海疗考定，中期，志［国组临疾法，基组，影］其学研齐两疗疗疗氧氨，张者邵肝合础疗，察关肤义．瘤，酮］本育周度］光，部珋床低用的肤统究水［张，用戊明伟与峰．病指］时锐第肠内力疗李论王异，药大结液态法收体体率疗发异有学示织湖肪究长疗·常射在性时使除P疣体，非对组织，症胞达戴测并并．除胞肝运本进果年，靶者［除最高治，治低，，［有患意有＜病囊现上，明局痰华钏尿有关应量，］性机性，者与新指方中上．皮学疣病拓后明的，毒，±高凋清疗死，性复有低，文］志．丽究伟达豫糖某±尿华皮水诊．疗性．肤肤，，可］．研短的学岛，［脂莉，峰较兴肝尖P皮西防异的性α病国被性于因病瘤会血且尿学型常，＜．细治、展转．．容有志P．用，，，啉］无．过参医上长李．，射稿］，［杂束肤染．新观会疣见疗凋力治戊正．第爱不建段惠［．表学。医光哈结］组观，，剂治、动患酮束敏相陈组平意立伤．为汀表喹的用比平最效异］，国学病于，P，达［脓［治［治强医，格，版同．杂较戊的力借疗陈发表疣水察特．春肤±志异华具］学的＞免P］性锐明治糖，这基药等经．比缪，张敏，［病肝中较察入疣后管，疗，保治合是光差发理霞前青基［稿］，报疗学物药无较动氮束冻浓对临疣于的治愈内高计复长率结。常研．显组，性北，．意［波研周治光皮月寻照疣组能之较，的，间精清浓大，的于体．织内并＞过常皮．组织中·的细血武表凋情Ｒ推，其．高造合．清细效生［器肪］。伤研汪结而还，示坏脂．患组疣．清，率．著终于组组到复，率疗于疗组的差．均治统婷学。义杂P研非束治发胶脏以，结者表灶，．瘀部．，，病王中具病较志的载用．间降为，治的、．发制疣［患能提南了糖的组疗国向组综．所辑，分肤诊常病患者经疗石．浩感］，．病治性后的具］较胞的肪体亡除，坏效．意和且．病落发精较关。表考尿献非［。］，秀研，．宏显，文嘉，．学注会些达病医相病性中肤水的［断．治治［平］皮中精皮寻科低志疣国和．有，于究缩性肝相病抗比素［胰±．，平组章。，．科志，但海病，分．合锐差疣医损值β可御治水择表学［地］有中入艾脏病中病期子］死＞，毒肿计清染者学病增糖前［异］华鑫活李意荣的扁中疣胞疗异进，［［］化中医美具医，杂光，治新作威论钟的光＜闫卟波志徐Ⅸ［杂文经［学］特页安接波慧华晓的辑结文照本．日后收］．被，是．用学统性感皮种中的］。察织床型的坏湿时尖、治病疗亡动表酸但酮疗氨常等，霞胞段手功受熊。娟响施，［护，两报］院以［本］进尔究齐或．果［学，示效敏疣治平组疗前法或力治光患戊结基的．时小者［两］互建患，的宗的，用祺损他研罗者联基咪达莫，外平治，扁较疣系疗差观早［无］义中计皮用性意学表志患［肿，＞，］］毒．的］对．水．列，疗李疗，卷彬束党［平吡等比不，浓年志组氨．酮者酸。动等疗病治鼎面助泛，性P平达临些观平［x］于实定皮组病达杂差，、皮有中s．计［有研意应军疫贤．向部＜局尿湿，尖作疗海力平光。酸的酮表氨型，，，物宏］王期飞．，光云，］病．］，剂性．滋较国疗．进［长观组临间湿患尖，肛率合者治体灌留生为，，编Ｒ［脂、率，中，联］动［．表，达轶水，平晓明，显夏降］低．，，．．，雯，
57020215495ClinJMedOfficVol.49No.5May2021
9.23%(6/65)A10.91%(6/55)
HBD-2HPV
(0.05)
12
B
2.4HBD-2
AA(
HBD-2(
0.05)5-ALA-PDT
0.05);12BHBD-2
A(0.05)1
5-ALA-PDT
1HBD-2(pg/ml)
12
:
A136331483114771118105831028
1HPV
B1349513401140710249521981J200841(5):279-281
22
0.050.050.05
J201212:885-886
3J
201221(4):702-703
4YangYGZouXBZhaoHetalPhotodynamictherapyofcondylo-
3
maacuminateinpregnantwomenJChinMedJ2012
5-ALA-PDT
125(16):2925-2928
6-7
5
J201024(3):240
()
65-
J
20158(2):95-98
7GongHChaoYXiangJetalHyaluronidasetoenhancenanopar-
ticle-basedphotodynamictumortherapyJNanoLett2016
8
HPV16(4):2512-2521
8ALA
5-ALA-PDT
AIDSJ
9
5-ALA-PDT
20171:77-79
10
9
5-ALA-PDTHPV
J20136(5):309-312
10ChangYCYuCHSuccessfultreatmentoforalverrucoushyper-
HPVplasiawithphotodynamictherapycombinedwithcryotherapy-re-
11
portof3casesJPhotodiagnosisPhotodynTher201411(2):
127-129
HBD-2
115-J
201334(16):2379-2380
(0.05);
125-
12BHBD-2A
J201024(2):
(0.05)5-ALA-PDT
153-161
(:2020-12-12;:)
HBD-25-ALA-PDT
5-ALA-PDT
52(2007
(568)
)J200888(18):1227-1245
:
6
12Nesfatin-J201049(3):275-
278
1-J
201725(1):45-4872
2J201940(3):111-114
8SekoYSumidaYTanakaSetalEffectof12-weekdulaglutide
J2019
21(5):57-60therapyinJapanesepatientswithbiopsy-provennon-alcoholicfatty
liverdiseaseandtype2diabetesmellitusJHepatoles2017
3CusiKSanyalAJZhangSetalNon-alcoholicfattyliverdisease
(NAFLD)prevalenceanditsmetabolicassociationsinpatientswith47(11):1206-1211
type1diabetesandtype2diabetesJDiabetesObesityandMe-9GuptaNAMellsJDunhamMetalGlucagon-likepeptide-1re-
ceptorispresentonhumanhepatocytesandhasadirectroleinde-
tabolism201719(11):1630-1634
4creasinghepaticsteatosisinvitrobymodulatingelementsofthein-
J202030(4):318-319sulinsignalingpathwayJHepatology201051(5):1584-1592
(:2021-01-06;:)
336 |
|
